Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion; Journal of Evolutionary Biochemistry and Physiology; Vol. 59, iss. 3

Dades bibliogràfiques
Parent link:Journal of Evolutionary Biochemistry and Physiology.— .— New York: Pleiades Publishing, Inc.
Vol. 59, iss. 3.— 2023.— P. 951-959
Altres autors: Zhilyaev S. Yu. Sergey Yurjevich, Platonova T. F. Tatjyana Fedorovna, Khlebnikov A. I. Andrey Ivanovich, Schepetkin (Shchepyotkin) I. A. Igor Aleksandrovich, Demchenko I. T. Ivan Timofeevich, Atochin D. N. Dmitry Nikolaevich
Sumari:Title screen
The aim of this study was to evaluate the vasoactive and neuroprotective effects of c-Jun N-terminal kinase inhibitor IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) in chronic cerebral hypoperfusion caused by irreversible bilateral common carotid artery ligation [two-vessel occlusion (2VO) model]. Cerebral blood flow was measured quantitatively (hydrogen clearance method) simultaneously in the parietal cortex, hippocampus, substantia nigra, and striatum of the brain of awake rats. It was found that 2VO caused a decrease in blood flow in the brain regions with a more pronounced decrease in the cortex (by 48% of the initial level) and with a minimum drop in the substantia nigra (by 25% of the initial level). The reduced level of blood flow persisted for 14 days of measurements. The responses of the cerebral vessels to hypercapnic probes (5% CO2) were lost during the 2-week hypoperfusion period, and the neurological status of the animals did not improve. The administration of IQ-1 (50 mg/kg, intraperitoneally, every 48 h for 14 days) was accompanied by an increase in blood flow in all brain regions. A maximum increase in blood flow was observed in the striatum and a minimum in the substantia nigra. After the administration of IQ-1, the sensitivity of the cerebral vessels to the hypercapnic stimulus was restored, and the neurological state of the animals significantly improved by the end of the second week of cerebral hypoperfusion. The results show that the use of the JNK inhibitor can reduce cerebrovascular disorders and related neurological disorders in hypoperfusion brain injur
Текстовый файл
AM_Agreement
Idioma:anglès
Publicat: 2023
Matèries:
Accés en línia:https://doi.org/10.1134/S0022093023030262
Format: Electrònic Capítol de llibre
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=680235

MARC

LEADER 00000naa0a2200000 4500
001 680235
005 20250515115121.0
090 |a 680235 
100 |a 20250515d2023 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion  |f S. Yu. Zhilyaev, T. F. Platonova, A. I. Khlebnikov [et al.] 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
320 |a References: 24 tit 
330 |a The aim of this study was to evaluate the vasoactive and neuroprotective effects of c-Jun N-terminal kinase inhibitor IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) in chronic cerebral hypoperfusion caused by irreversible bilateral common carotid artery ligation [two-vessel occlusion (2VO) model]. Cerebral blood flow was measured quantitatively (hydrogen clearance method) simultaneously in the parietal cortex, hippocampus, substantia nigra, and striatum of the brain of awake rats. It was found that 2VO caused a decrease in blood flow in the brain regions with a more pronounced decrease in the cortex (by 48% of the initial level) and with a minimum drop in the substantia nigra (by 25% of the initial level). The reduced level of blood flow persisted for 14 days of measurements. The responses of the cerebral vessels to hypercapnic probes (5% CO2) were lost during the 2-week hypoperfusion period, and the neurological status of the animals did not improve. The administration of IQ-1 (50 mg/kg, intraperitoneally, every 48 h for 14 days) was accompanied by an increase in blood flow in all brain regions. A maximum increase in blood flow was observed in the striatum and a minimum in the substantia nigra. After the administration of IQ-1, the sensitivity of the cerebral vessels to the hypercapnic stimulus was restored, and the neurological state of the animals significantly improved by the end of the second week of cerebral hypoperfusion. The results show that the use of the JNK inhibitor can reduce cerebrovascular disorders and related neurological disorders in hypoperfusion brain injur 
336 |a Текстовый файл 
371 0 |a AM_Agreement 
461 1 |t Journal of Evolutionary Biochemistry and Physiology  |c New York  |n Pleiades Publishing, Inc. 
463 1 |t Vol. 59, iss. 3  |v P. 951-959  |d 2023 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a c-Jun N-terminal kinase inhibitors 
610 1 |a chronic cerebral hypoperfusion 
610 1 |a cerebral blood flow 
610 1 |a neuroprotection 
610 1 |a hypercapnic probe 
610 1 |a striatum 
610 1 |a substantia nigra 
701 1 |a Zhilyaev  |b S. Yu.  |g Sergey Yurjevich 
701 1 |a Platonova  |b T. F.  |g Tatjyana Fedorovna 
701 1 |a Khlebnikov  |b A. I.  |c Chemist  |c Professor of Tomsk Polytechnic University  |f 1963-  |g Andrey Ivanovich  |9 17500 
701 1 |a Schepetkin (Shchepyotkin)  |b I. A.  |c doctor-biophysicist  |c leading researcher of Tomsk Polytechnic University, candidate of medical science  |f 1962-  |g Igor Aleksandrovich  |9 20276 
701 1 |a Demchenko  |b I. T.  |g Ivan Timofeevich 
701 1 |a Atochin  |b D. N.  |c neuroscientist  |c The Head of the Laboratory of Tomsk Polytechnic University  |f 1960-  |g Dmitry Nikolaevich  |9 20383 
801 0 |a RU  |b 63413507  |c 20250515  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.1134/S0022093023030262  |z https://doi.org/10.1134/S0022093023030262 
942 |c CF